I spoke with Cruz-Fernández and Ackerman about their approach to documenting the history of local businesses in Gainesville, the significance of restaurants with that special sense of place, and ...

NHK has learned that work to remove molten fuel debris at the Fukushima Daiichi nuclear power plant is not likely to start until the late 2030s at the earliest.

Cam Indexer Technology, Sankyo Automation’s specialty, encapsulates our dedication to innovating in motion control. We continuously develop new technologies to enhance this field. Our high-speed, high ...

This paper presents a simple and efficient screening protocol for optical resolution by diastereomeric salt crystallization, developed from an analysis of our historical data. Original screening kits ...

Laura McMullin, General Manager, Daiichi Sankyo UK, has been appointed Vice President of the ABPI to support UK life sciences innovation.

Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a competitive field. Hiroyuki Okuzawa is working to keep it that way. Some two dozen ...

The FDA has granted breakthrough therapy designation to the combination of fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) and pertuzumab (Perjeta) for the first-line treatment of adult patients with ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug substance plant in Japan. | The company attributed its decision to ...

NSCLC driven by mutations in HER2 may be treated in the later lines with the HER2-targeted ADC trastuzumab deruxtecan (Enhertu; AstraZeneca/Daiichi Sankyo).

The company refused the FDA’s request and will continue shipping its therapy, Elevidys, to Duchenne patients who can still walk. A pause on shipments to older, non-ambulatory patients remains in place ...